Top Markets
Coin of the day
Satsuma Pharmaceuticals, Inc. Satsuma Pharmaceuticals, Inc.

Satsuma Pharmaceuticals, Inc.

STSA
주식 순위 #29900
Satsuma Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm... Satsuma Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing innovative therapies for the rapid relief of migraines. Its lead therapeutic candidate, STS101, is an integrated drug-device system comprising a proprietary dry-powder formulation of dihydroergotamine mesylate. Currently, STS101 is progressing through its pivotal SUMMIT Phase 3 efficacy trials and is designed for self-administration via a specialized, pre-filled, single-use nasal delivery device. Established in 2016, the company maintains its headquarters in South San Francisco, California.
주가
$1.10
마지막 동기화: 2023-06-07
시가총액
$19.12M
변동 (1일)
-0.90%
변동 (1년)
0.00%
국가
US
거래 Satsuma Pharmaceuticals, Inc. (STSA)

카테고리

Satsuma Pharmaceuticals, Inc. (STSA)의 주가 이력
최고 종가: $1.08 (2023-06-01 기준)

최저 종가: $15.51 (2019-09-01 기준)
Satsuma Pharmaceuticals, Inc.의 주가 이력 (2019 ~ 2026)
연간 주가 성과
연도 성과
2023 24.48%
2022 -81.02%
2021 -5.23%
2020 -69.52%
2019 0.00%
유사 기업 또는 경쟁사의 주가
회사 주가 변동률 1년% 국가
$527.89 35.09%
US
$996.61 51.72%
NL
$117.42 -19.34%
AU
$743.14 7.12%
CH
$1.07K -5.58%
KR